Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Results of the Randomized I-BFM-SG Trial „Acute Lymphoblastic Leukemia Intercontinental-BFM 2002“ in 5060 Children Diagnosed in 15 Countries on 3 Continents

Blood (2011) 118 (21): 872.

https://doi.org/10.1182/blood.V118.21.872.872

Published: 2011

Journal Articles

Risk-Adjusted Therapy of Acute Lymphoblastic Leukemia Can Decrease Treatment Burden and Improve Survival: Treatment Results of 2169 Unselected Pediatric and Adolescent Patients Enrolled in the Trial ALL-BFM 95.

Anja Möricke, MD, Alfred Reiter, MD, Martin Zimmermann, PhD, Helmut Gadner, MD, Martin Stanulla, MD, Wolf-Dieter Ludwig, MD, Jochen Harbott, PhD, Georg Mann, MD, Felix Niggli, MD, Günter Henze, MD, Karl Welte, MD, Thomas Klingebiel, MD, Charlotte Niemeyer, MD, Felix Zintl, MD, Hansjörg Riehm, MD, Martin Schrappe, MD

Blood (2007) 110 (11): 584.

https://doi.org/10.1182/blood.V110.11.584.584

Published: 2007

Journal Articles

CNS Involvement in Childhood and Adolescence Non-Hodgkin Lymphoma: Prevalence and Patient’s Outcome Differ According to the Subtype.

Janina Salzburg, MD, Birgit Burkhardt, MD, Olga Wachowski, MD, Martin Zimmermann, PhD, Reza Parwaresch, MD, Wolf-Dieter Ludwig, MD, Georg Mann, MD, Felix Niggli, MD, Hansjörg Riehm, MD, Martin Schrappe, MD, Alfred Reiter, MD

Blood (2005) 106 (11): 233.

https://doi.org/10.1182/blood.V106.11.233.233

Published: 2005

Journal Articles

Prognostic Factors in CD10 Negative Precursor B-Cell Acute Lymphoblastic Leukemia in Children: Data from Three Consecutive Trials ALL-BFM 86, 90, and 95.

Anja Möricke, MD, Richard Ratei, MD, Wolf-Dieter Ludwig, MD, PhD, Jochen Harbott, PhD, Arndt Borkhardt, MD, PhD, Susanne Viehmann, PhD, Martin Zimmermann, PhD, Helmut Gadner, MD, PhD, Hansjörg Riehm, MD, PhD, Martin Schrappe, MD, PhD

Blood (2004) 104 (11): 1957.

https://doi.org/10.1182/blood.V104.11.1957.1957

Published: 2004

Journal Articles

Short-pulse B–non-Hodgkin lymphoma–type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90

Kathrin Seidemann, Markus Tiemann, Martin Schrappe, Elif Yakisan, Ingrid Simonitsch, Gritta Janka-Schaub, Wolfgang Dörffel, Martin Zimmermann, Georg Mann, Helmut Gadner, Reza Parwaresch, Hansjörg Riehm, Alfred Reiter

Blood (2001) 97 (12): 3699–3706.

https://doi.org/10.1182/blood.V97.12.3699

Published: 2001

Journal Articles

Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90

Martin Schrappe, Alfred Reiter, Wolf-Dieter Ludwig, Jochen Harbott, Martin Zimmermann, Wolfgang Hiddemann, Charlotte Niemeyer, Günter Henze, Andreas Feldges, Felix Zintl, Bernhard Kornhuber, Jörg Ritter, Karl Welte, Helmut Gadner, Hansjörg Riehm

Blood (2000) 95 (11): 3310–3322.

https://doi.org/10.1182/blood.V95.11.3310

Published: 2000

Journal Articles

Secondary neoplasms subsequent to Berlin-Frankfurt-Münster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy

Lutz Löning, Martin Zimmermann, Alfred Reiter, Peter Kaatsch, Günter Henze, Hansjörg Riehm, Martin Schrappe

Blood (2000) 95 (9): 2770–2775.

https://doi.org/10.1182/blood.V95.9.2770.009k16_2770_2775

Published: 2000

Journal Articles

Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM Group report

Alfred Reiter, Martin Schrappe, Wolf-Dieter Ludwig, Markus Tiemann, Reza Parwaresch, Martin Zimmermann, Eckard Schirg, Günter Henze, Günther Schellong, Helmut Gadner, Hansjörg Riehm

Blood (2000) 95 (2): 416–421.

https://doi.org/10.1182/blood.V95.2.416

Published: 2000

Journal Articles

Improved Treatment Results in Childhood B-Cell Neoplasms With Tailored Intensification of Therapy: A Report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90

Alfred Reiter, Martin Schrappe, Markus Tiemann, Wolf-Dieter Ludwig, Elif Yakisan, Martin Zimmermann, Georg Mann, Andreas Chott, Wolfram Ebell, Thomas Klingebiel, Norbert Graf, Bernhard Kremens, Stefan Müller-Weihrich, Hans-Jürgen Plüss, Felix Zintl, Günter Henze, Hansjörg Riehm

Blood (1999) 94 (10): 3294–3306.

https://doi.org/10.1182/blood.V94.10.3294.422k12_3294_3306

Published: 1999

Journal Articles

Prednisone Response Is the Strongest Predictor of Treatment Outcome in Infant Acute Lymphoblastic Leukemia

Michael Dördelmann, Alfred Reiter, Arndt Borkhardt, Wolf-Dieter Ludwig, Nicolai Götz, Susanne Viehmann, Helmut Gadner, Hansjörg Riehm, Martin Schrappe

Blood (1999) 94 (4): 1209–1217.

https://doi.org/10.1182/blood.V94.4.1209

Published: 1999

Journal Articles

Philadelphia Chromosome-Positive (Ph + ) Childhood Acute Lymphoblastic Leukemia: Good Initial Steroid Response Allows Early Prediction of a Favorable Treatment Outcome

Martin Schrappe, Maurizio Aricò, Jochen Harbott, Andrea Biondi, Martin Zimmermann, Valentino Conter, Alfred Reiter, Maria G. Valsecchi, Helmut Gadner, Giuseppe Basso, Claus R. Bartram, Fritz Lampert, Hansjörg Riehm, Giuseppe Masera

Blood (1998) 92 (8): 2730–2741.

https://doi.org/10.1182/blood.V92.8.2730

Published: 1998

Journal Articles

Incidence and Clinical Relevance of TEL/AML1 Fusion Genes in Children With Acute Lymphoblastic Leukemia Enrolled in the German and Italian Multicenter Therapy Trials

Arndt Borkhardt, Giovanni Cazzaniga, Susanne Viehmann, Maria Grazia Valsecchi, Wolf Dieter Ludwig, Linda Burci, Silvia Mangioni, Martin Schrappe, Hansjörg Riehm, Fritz Lampert, Giuseppe Basso, Giuseppe Masera, Jochen Harbott, Andrea Biondi

Blood (1997) 90 (2): 571–577.

https://doi.org/10.1182/blood.V90.2.571

Published: 1997

NARROW

Results of the Randomized I-BFM-SG Trial „Acute Lymphoblastic Leukemia Intercontinental-BFM 2002“ in 5060 Children Diagnosed in 15 Countries on 3 Continents

Risk-Adjusted Therapy of Acute Lymphoblastic Leukemia Can Decrease Treatment Burden and Improve Survival: Treatment Results of 2169 Unselected Pediatric and Adolescent Patients Enrolled in the Trial ALL-BFM 95.

CNS Involvement in Childhood and Adolescence Non-Hodgkin Lymphoma: Prevalence and Patient’s Outcome Differ According to the Subtype.

Prognostic Factors in CD10 Negative Precursor B-Cell Acute Lymphoblastic Leukemia in Children: Data from Three Consecutive Trials ALL-BFM 86, 90, and 95.

Short-pulse B–non-Hodgkin lymphoma–type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90

Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90

Secondary neoplasms subsequent to Berlin-Frankfurt-Münster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy

Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM Group report

Improved Treatment Results in Childhood B-Cell Neoplasms With Tailored Intensification of Therapy: A Report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90

Prednisone Response Is the Strongest Predictor of Treatment Outcome in Infant Acute Lymphoblastic Leukemia

Philadelphia Chromosome-Positive (Ph + ) Childhood Acute Lymphoblastic Leukemia: Good Initial Steroid Response Allows Early Prediction of a Favorable Treatment Outcome

Incidence and Clinical Relevance of TEL/AML1 Fusion Genes in Children With Acute Lymphoblastic Leukemia Enrolled in the German and Italian Multicenter Therapy Trials

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only